nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—CYP3A4—Thiotepa—sarcoma	0.153	0.202	CbGbCtD
Ticagrelor—ABCB1—Dactinomycin—sarcoma	0.123	0.162	CbGbCtD
Ticagrelor—ABCB1—Mitoxantrone—sarcoma	0.11	0.145	CbGbCtD
Ticagrelor—ABCB1—Vincristine—sarcoma	0.0755	0.0996	CbGbCtD
Ticagrelor—ABCB1—Etoposide—sarcoma	0.0692	0.0913	CbGbCtD
Ticagrelor—CYP3A4—Mitoxantrone—sarcoma	0.0657	0.0867	CbGbCtD
Ticagrelor—ABCB1—Doxorubicin—sarcoma	0.0472	0.0623	CbGbCtD
Ticagrelor—CYP3A4—Vincristine—sarcoma	0.0452	0.0597	CbGbCtD
Ticagrelor—CYP3A4—Etoposide—sarcoma	0.0415	0.0547	CbGbCtD
Ticagrelor—CYP3A4—Doxorubicin—sarcoma	0.0283	0.0373	CbGbCtD
Ticagrelor—Urethral disorder—Vincristine—sarcoma	0.000967	0.00399	CcSEcCtD
Ticagrelor—Neoplasm malignant—Doxorubicin—sarcoma	0.000966	0.00399	CcSEcCtD
Ticagrelor—Haemoglobin—Mitoxantrone—sarcoma	0.000966	0.00399	CcSEcCtD
Ticagrelor—Hyperuricaemia—Epirubicin—sarcoma	0.000961	0.00397	CcSEcCtD
Ticagrelor—Haemorrhage—Mitoxantrone—sarcoma	0.000961	0.00397	CcSEcCtD
Ticagrelor—Back pain—Thiotepa—sarcoma	0.000937	0.00387	CcSEcCtD
Ticagrelor—Cardiac disorder—Vincristine—sarcoma	0.000915	0.00378	CcSEcCtD
Ticagrelor—Rectal haemorrhage—Doxorubicin—sarcoma	0.000914	0.00377	CcSEcCtD
Ticagrelor—Bone disorder—Doxorubicin—sarcoma	0.000914	0.00377	CcSEcCtD
Ticagrelor—Blood uric acid increased—Epirubicin—sarcoma	0.000908	0.00375	CcSEcCtD
Ticagrelor—Oliguria—Doxorubicin—sarcoma	0.000896	0.0037	CcSEcCtD
Ticagrelor—Angiopathy—Vincristine—sarcoma	0.000895	0.00369	CcSEcCtD
Ticagrelor—Hyperuricaemia—Doxorubicin—sarcoma	0.00089	0.00367	CcSEcCtD
Ticagrelor—Mediastinal disorder—Vincristine—sarcoma	0.000889	0.00367	CcSEcCtD
Ticagrelor—Melaena—Epirubicin—sarcoma	0.000871	0.0036	CcSEcCtD
Ticagrelor—Mental disorder—Vincristine—sarcoma	0.000864	0.00357	CcSEcCtD
Ticagrelor—Cough—Thiotepa—sarcoma	0.000845	0.00349	CcSEcCtD
Ticagrelor—Blood uric acid increased—Doxorubicin—sarcoma	0.00084	0.00347	CcSEcCtD
Ticagrelor—Hypertension—Thiotepa—sarcoma	0.000836	0.00345	CcSEcCtD
Ticagrelor—Back pain—Vincristine—sarcoma	0.000831	0.00343	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000819	0.00338	CcSEcCtD
Ticagrelor—Back pain—Mitoxantrone—sarcoma	0.000809	0.00334	CcSEcCtD
Ticagrelor—Ecchymosis—Epirubicin—sarcoma	0.000806	0.00333	CcSEcCtD
Ticagrelor—Melaena—Doxorubicin—sarcoma	0.000806	0.00333	CcSEcCtD
Ticagrelor—Confusional state—Thiotepa—sarcoma	0.000797	0.00329	CcSEcCtD
Ticagrelor—Urinary tract disorder—Etoposide—sarcoma	0.000789	0.00326	CcSEcCtD
Ticagrelor—Urethral disorder—Etoposide—sarcoma	0.000783	0.00323	CcSEcCtD
Ticagrelor—Nervous system disorder—Thiotepa—sarcoma	0.000775	0.0032	CcSEcCtD
Ticagrelor—Vertigo—Vincristine—sarcoma	0.000771	0.00318	CcSEcCtD
Ticagrelor—Skin disorder—Thiotepa—sarcoma	0.000768	0.00317	CcSEcCtD
Ticagrelor—Eye disorder—Etoposide—sarcoma	0.000747	0.00308	CcSEcCtD
Ticagrelor—Ecchymosis—Doxorubicin—sarcoma	0.000746	0.00308	CcSEcCtD
Ticagrelor—Cardiac disorder—Etoposide—sarcoma	0.000742	0.00306	CcSEcCtD
Ticagrelor—Hypertension—Vincristine—sarcoma	0.000741	0.00306	CcSEcCtD
Ticagrelor—Cough—Mitoxantrone—sarcoma	0.00073	0.00301	CcSEcCtD
Ticagrelor—Angiopathy—Etoposide—sarcoma	0.000725	0.00299	CcSEcCtD
Ticagrelor—Hypertension—Mitoxantrone—sarcoma	0.000722	0.00298	CcSEcCtD
Ticagrelor—Immune system disorder—Etoposide—sarcoma	0.000722	0.00298	CcSEcCtD
Ticagrelor—Mediastinal disorder—Etoposide—sarcoma	0.00072	0.00297	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Epirubicin—sarcoma	0.000714	0.00295	CcSEcCtD
Ticagrelor—Chest pain—Mitoxantrone—sarcoma	0.000712	0.00294	CcSEcCtD
Ticagrelor—Paraesthesia—Thiotepa—sarcoma	0.00071	0.00293	CcSEcCtD
Ticagrelor—Renal failure acute—Epirubicin—sarcoma	0.000701	0.00289	CcSEcCtD
Ticagrelor—Dyspepsia—Thiotepa—sarcoma	0.000696	0.00287	CcSEcCtD
Ticagrelor—Confusional state—Mitoxantrone—sarcoma	0.000688	0.00284	CcSEcCtD
Ticagrelor—Nervous system disorder—Vincristine—sarcoma	0.000687	0.00284	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Thiotepa—sarcoma	0.000682	0.00282	CcSEcCtD
Ticagrelor—Fatigue—Thiotepa—sarcoma	0.000681	0.00281	CcSEcCtD
Ticagrelor—Fatigue—Dactinomycin—sarcoma	0.000676	0.00279	CcSEcCtD
Ticagrelor—Constipation—Thiotepa—sarcoma	0.000676	0.00279	CcSEcCtD
Ticagrelor—Back pain—Etoposide—sarcoma	0.000673	0.00278	CcSEcCtD
Ticagrelor—Shock—Mitoxantrone—sarcoma	0.000671	0.00277	CcSEcCtD
Ticagrelor—Cardiac failure—Epirubicin—sarcoma	0.000663	0.00274	CcSEcCtD
Ticagrelor—Skin disorder—Mitoxantrone—sarcoma	0.000663	0.00274	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Doxorubicin—sarcoma	0.000661	0.00273	CcSEcCtD
Ticagrelor—Hypotension—Vincristine—sarcoma	0.000655	0.0027	CcSEcCtD
Ticagrelor—Feeling abnormal—Thiotepa—sarcoma	0.000651	0.00269	CcSEcCtD
Ticagrelor—Renal failure acute—Doxorubicin—sarcoma	0.000649	0.00268	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000647	0.00267	CcSEcCtD
Ticagrelor—Feeling abnormal—Dactinomycin—sarcoma	0.000646	0.00267	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Thiotepa—sarcoma	0.000646	0.00267	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Dactinomycin—sarcoma	0.000641	0.00265	CcSEcCtD
Ticagrelor—Hypotension—Mitoxantrone—sarcoma	0.000638	0.00263	CcSEcCtD
Ticagrelor—Paraesthesia—Vincristine—sarcoma	0.000629	0.0026	CcSEcCtD
Ticagrelor—Vertigo—Etoposide—sarcoma	0.000625	0.00258	CcSEcCtD
Ticagrelor—Abdominal pain—Thiotepa—sarcoma	0.000625	0.00258	CcSEcCtD
Ticagrelor—Body temperature increased—Thiotepa—sarcoma	0.000625	0.00258	CcSEcCtD
Ticagrelor—Abdominal pain—Dactinomycin—sarcoma	0.00062	0.00256	CcSEcCtD
Ticagrelor—Body temperature increased—Dactinomycin—sarcoma	0.00062	0.00256	CcSEcCtD
Ticagrelor—Cardiac failure—Doxorubicin—sarcoma	0.000614	0.00253	CcSEcCtD
Ticagrelor—Paraesthesia—Mitoxantrone—sarcoma	0.000613	0.00253	CcSEcCtD
Ticagrelor—Loss of consciousness—Etoposide—sarcoma	0.000611	0.00252	CcSEcCtD
Ticagrelor—Dyspnoea—Mitoxantrone—sarcoma	0.000608	0.00251	CcSEcCtD
Ticagrelor—Cough—Etoposide—sarcoma	0.000607	0.00251	CcSEcCtD
Ticagrelor—Blood creatinine increased—Epirubicin—sarcoma	0.000607	0.0025	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Vincristine—sarcoma	0.000605	0.0025	CcSEcCtD
Ticagrelor—Fatigue—Vincristine—sarcoma	0.000604	0.00249	CcSEcCtD
Ticagrelor—Dyspepsia—Mitoxantrone—sarcoma	0.000601	0.00248	CcSEcCtD
Ticagrelor—Hypertension—Etoposide—sarcoma	0.000601	0.00248	CcSEcCtD
Ticagrelor—Constipation—Vincristine—sarcoma	0.000599	0.00247	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000599	0.00247	CcSEcCtD
Ticagrelor—Chest pain—Etoposide—sarcoma	0.000592	0.00244	CcSEcCtD
Ticagrelor—Fatigue—Mitoxantrone—sarcoma	0.000588	0.00243	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000588	0.00243	CcSEcCtD
Ticagrelor—Breast disorder—Epirubicin—sarcoma	0.000585	0.00242	CcSEcCtD
Ticagrelor—Constipation—Mitoxantrone—sarcoma	0.000584	0.00241	CcSEcCtD
Ticagrelor—Hypersensitivity—Thiotepa—sarcoma	0.000582	0.0024	CcSEcCtD
Ticagrelor—Hypersensitivity—Dactinomycin—sarcoma	0.000578	0.00239	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Vincristine—sarcoma	0.000573	0.00237	CcSEcCtD
Ticagrelor—Gastritis—Epirubicin—sarcoma	0.000573	0.00237	CcSEcCtD
Ticagrelor—Confusional state—Etoposide—sarcoma	0.000572	0.00236	CcSEcCtD
Ticagrelor—Asthenia—Thiotepa—sarcoma	0.000567	0.00234	CcSEcCtD
Ticagrelor—Asthenia—Dactinomycin—sarcoma	0.000563	0.00232	CcSEcCtD
Ticagrelor—Feeling abnormal—Mitoxantrone—sarcoma	0.000562	0.00232	CcSEcCtD
Ticagrelor—Blood creatinine increased—Doxorubicin—sarcoma	0.000561	0.00232	CcSEcCtD
Ticagrelor—Pruritus—Thiotepa—sarcoma	0.000559	0.00231	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000558	0.0023	CcSEcCtD
Ticagrelor—Abdominal pain—Vincristine—sarcoma	0.000554	0.00229	CcSEcCtD
Ticagrelor—Body temperature increased—Vincristine—sarcoma	0.000554	0.00229	CcSEcCtD
Ticagrelor—Skin disorder—Etoposide—sarcoma	0.000551	0.00228	CcSEcCtD
Ticagrelor—Breast disorder—Doxorubicin—sarcoma	0.000541	0.00223	CcSEcCtD
Ticagrelor—Diarrhoea—Thiotepa—sarcoma	0.000541	0.00223	CcSEcCtD
Ticagrelor—Body temperature increased—Mitoxantrone—sarcoma	0.00054	0.00223	CcSEcCtD
Ticagrelor—Abdominal pain—Mitoxantrone—sarcoma	0.00054	0.00223	CcSEcCtD
Ticagrelor—Diarrhoea—Dactinomycin—sarcoma	0.000537	0.00222	CcSEcCtD
Ticagrelor—Hypotension—Etoposide—sarcoma	0.00053	0.00219	CcSEcCtD
Ticagrelor—Gastritis—Doxorubicin—sarcoma	0.00053	0.00219	CcSEcCtD
Ticagrelor—Dizziness—Thiotepa—sarcoma	0.000523	0.00216	CcSEcCtD
Ticagrelor—Hypersensitivity—Vincristine—sarcoma	0.000516	0.00213	CcSEcCtD
Ticagrelor—Paraesthesia—Etoposide—sarcoma	0.00051	0.0021	CcSEcCtD
Ticagrelor—Dyspnoea—Etoposide—sarcoma	0.000506	0.00209	CcSEcCtD
Ticagrelor—Hypersensitivity—Mitoxantrone—sarcoma	0.000503	0.00208	CcSEcCtD
Ticagrelor—Asthenia—Vincristine—sarcoma	0.000503	0.00208	CcSEcCtD
Ticagrelor—Vomiting—Thiotepa—sarcoma	0.000502	0.00207	CcSEcCtD
Ticagrelor—Vomiting—Dactinomycin—sarcoma	0.000499	0.00206	CcSEcCtD
Ticagrelor—Rash—Thiotepa—sarcoma	0.000498	0.00206	CcSEcCtD
Ticagrelor—Dermatitis—Thiotepa—sarcoma	0.000498	0.00206	CcSEcCtD
Ticagrelor—Headache—Thiotepa—sarcoma	0.000495	0.00204	CcSEcCtD
Ticagrelor—Rash—Dactinomycin—sarcoma	0.000495	0.00204	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Etoposide—sarcoma	0.00049	0.00202	CcSEcCtD
Ticagrelor—Asthenia—Mitoxantrone—sarcoma	0.00049	0.00202	CcSEcCtD
Ticagrelor—Fatigue—Etoposide—sarcoma	0.000489	0.00202	CcSEcCtD
Ticagrelor—Constipation—Etoposide—sarcoma	0.000485	0.002	CcSEcCtD
Ticagrelor—Diarrhoea—Vincristine—sarcoma	0.000479	0.00198	CcSEcCtD
Ticagrelor—Haematuria—Epirubicin—sarcoma	0.000476	0.00196	CcSEcCtD
Ticagrelor—Epistaxis—Epirubicin—sarcoma	0.000471	0.00194	CcSEcCtD
Ticagrelor—Nausea—Thiotepa—sarcoma	0.000469	0.00194	CcSEcCtD
Ticagrelor—Feeling abnormal—Etoposide—sarcoma	0.000468	0.00193	CcSEcCtD
Ticagrelor—Diarrhoea—Mitoxantrone—sarcoma	0.000467	0.00193	CcSEcCtD
Ticagrelor—Nausea—Dactinomycin—sarcoma	0.000466	0.00192	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Etoposide—sarcoma	0.000464	0.00192	CcSEcCtD
Ticagrelor—Dizziness—Vincristine—sarcoma	0.000463	0.00191	CcSEcCtD
Ticagrelor—Bradycardia—Epirubicin—sarcoma	0.000456	0.00188	CcSEcCtD
Ticagrelor—Haemoglobin—Epirubicin—sarcoma	0.00045	0.00186	CcSEcCtD
Ticagrelor—Body temperature increased—Etoposide—sarcoma	0.000449	0.00185	CcSEcCtD
Ticagrelor—Abdominal pain—Etoposide—sarcoma	0.000449	0.00185	CcSEcCtD
Ticagrelor—Haemorrhage—Epirubicin—sarcoma	0.000448	0.00185	CcSEcCtD
Ticagrelor—Vomiting—Vincristine—sarcoma	0.000446	0.00184	CcSEcCtD
Ticagrelor—Urinary tract disorder—Epirubicin—sarcoma	0.000442	0.00183	CcSEcCtD
Ticagrelor—Rash—Vincristine—sarcoma	0.000442	0.00182	CcSEcCtD
Ticagrelor—Dermatitis—Vincristine—sarcoma	0.000441	0.00182	CcSEcCtD
Ticagrelor—Oedema peripheral—Epirubicin—sarcoma	0.000441	0.00182	CcSEcCtD
Ticagrelor—Haematuria—Doxorubicin—sarcoma	0.00044	0.00182	CcSEcCtD
Ticagrelor—Connective tissue disorder—Epirubicin—sarcoma	0.00044	0.00182	CcSEcCtD
Ticagrelor—Urethral disorder—Epirubicin—sarcoma	0.000439	0.00181	CcSEcCtD
Ticagrelor—Headache—Vincristine—sarcoma	0.000439	0.00181	CcSEcCtD
Ticagrelor—Epistaxis—Doxorubicin—sarcoma	0.000435	0.0018	CcSEcCtD
Ticagrelor—Vomiting—Mitoxantrone—sarcoma	0.000434	0.00179	CcSEcCtD
Ticagrelor—Rash—Mitoxantrone—sarcoma	0.00043	0.00178	CcSEcCtD
Ticagrelor—Dermatitis—Mitoxantrone—sarcoma	0.00043	0.00177	CcSEcCtD
Ticagrelor—Headache—Mitoxantrone—sarcoma	0.000428	0.00176	CcSEcCtD
Ticagrelor—Bradycardia—Doxorubicin—sarcoma	0.000422	0.00174	CcSEcCtD
Ticagrelor—Eye disorder—Epirubicin—sarcoma	0.000419	0.00173	CcSEcCtD
Ticagrelor—Hypersensitivity—Etoposide—sarcoma	0.000418	0.00173	CcSEcCtD
Ticagrelor—Haemoglobin—Doxorubicin—sarcoma	0.000417	0.00172	CcSEcCtD
Ticagrelor—Nausea—Vincristine—sarcoma	0.000416	0.00172	CcSEcCtD
Ticagrelor—Cardiac disorder—Epirubicin—sarcoma	0.000416	0.00172	CcSEcCtD
Ticagrelor—Haemorrhage—Doxorubicin—sarcoma	0.000414	0.00171	CcSEcCtD
Ticagrelor—Urinary tract disorder—Doxorubicin—sarcoma	0.000409	0.00169	CcSEcCtD
Ticagrelor—Oedema peripheral—Doxorubicin—sarcoma	0.000408	0.00169	CcSEcCtD
Ticagrelor—Asthenia—Etoposide—sarcoma	0.000407	0.00168	CcSEcCtD
Ticagrelor—Connective tissue disorder—Doxorubicin—sarcoma	0.000407	0.00168	CcSEcCtD
Ticagrelor—Angiopathy—Epirubicin—sarcoma	0.000406	0.00168	CcSEcCtD
Ticagrelor—Urethral disorder—Doxorubicin—sarcoma	0.000406	0.00168	CcSEcCtD
Ticagrelor—Nausea—Mitoxantrone—sarcoma	0.000405	0.00167	CcSEcCtD
Ticagrelor—Immune system disorder—Epirubicin—sarcoma	0.000405	0.00167	CcSEcCtD
Ticagrelor—Mediastinal disorder—Epirubicin—sarcoma	0.000404	0.00167	CcSEcCtD
Ticagrelor—Pruritus—Etoposide—sarcoma	0.000402	0.00166	CcSEcCtD
Ticagrelor—Mental disorder—Epirubicin—sarcoma	0.000392	0.00162	CcSEcCtD
Ticagrelor—Malnutrition—Epirubicin—sarcoma	0.00039	0.00161	CcSEcCtD
Ticagrelor—Diarrhoea—Etoposide—sarcoma	0.000388	0.0016	CcSEcCtD
Ticagrelor—Eye disorder—Doxorubicin—sarcoma	0.000387	0.0016	CcSEcCtD
Ticagrelor—Cardiac disorder—Doxorubicin—sarcoma	0.000385	0.00159	CcSEcCtD
Ticagrelor—Back pain—Epirubicin—sarcoma	0.000377	0.00156	CcSEcCtD
Ticagrelor—Angiopathy—Doxorubicin—sarcoma	0.000376	0.00155	CcSEcCtD
Ticagrelor—Dizziness—Etoposide—sarcoma	0.000375	0.00155	CcSEcCtD
Ticagrelor—Immune system disorder—Doxorubicin—sarcoma	0.000374	0.00155	CcSEcCtD
Ticagrelor—Mediastinal disorder—Doxorubicin—sarcoma	0.000374	0.00154	CcSEcCtD
Ticagrelor—Mental disorder—Doxorubicin—sarcoma	0.000363	0.0015	CcSEcCtD
Ticagrelor—Vomiting—Etoposide—sarcoma	0.000361	0.00149	CcSEcCtD
Ticagrelor—Malnutrition—Doxorubicin—sarcoma	0.000361	0.00149	CcSEcCtD
Ticagrelor—Rash—Etoposide—sarcoma	0.000358	0.00148	CcSEcCtD
Ticagrelor—Dermatitis—Etoposide—sarcoma	0.000358	0.00148	CcSEcCtD
Ticagrelor—Headache—Etoposide—sarcoma	0.000356	0.00147	CcSEcCtD
Ticagrelor—Vertigo—Epirubicin—sarcoma	0.00035	0.00145	CcSEcCtD
Ticagrelor—Syncope—Epirubicin—sarcoma	0.00035	0.00144	CcSEcCtD
Ticagrelor—Back pain—Doxorubicin—sarcoma	0.000349	0.00144	CcSEcCtD
Ticagrelor—Loss of consciousness—Epirubicin—sarcoma	0.000343	0.00141	CcSEcCtD
Ticagrelor—Cough—Epirubicin—sarcoma	0.00034	0.0014	CcSEcCtD
Ticagrelor—Nausea—Etoposide—sarcoma	0.000337	0.00139	CcSEcCtD
Ticagrelor—Hypertension—Epirubicin—sarcoma	0.000337	0.00139	CcSEcCtD
Ticagrelor—Chest pain—Epirubicin—sarcoma	0.000332	0.00137	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00033	0.00136	CcSEcCtD
Ticagrelor—Vertigo—Doxorubicin—sarcoma	0.000324	0.00134	CcSEcCtD
Ticagrelor—Syncope—Doxorubicin—sarcoma	0.000324	0.00134	CcSEcCtD
Ticagrelor—Confusional state—Epirubicin—sarcoma	0.000321	0.00132	CcSEcCtD
Ticagrelor—Loss of consciousness—Doxorubicin—sarcoma	0.000317	0.00131	CcSEcCtD
Ticagrelor—Cough—Doxorubicin—sarcoma	0.000315	0.0013	CcSEcCtD
Ticagrelor—Shock—Epirubicin—sarcoma	0.000313	0.00129	CcSEcCtD
Ticagrelor—Nervous system disorder—Epirubicin—sarcoma	0.000312	0.00129	CcSEcCtD
Ticagrelor—Hypertension—Doxorubicin—sarcoma	0.000311	0.00129	CcSEcCtD
Ticagrelor—Skin disorder—Epirubicin—sarcoma	0.000309	0.00128	CcSEcCtD
Ticagrelor—Chest pain—Doxorubicin—sarcoma	0.000307	0.00127	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000305	0.00126	CcSEcCtD
Ticagrelor—Hypotension—Epirubicin—sarcoma	0.000297	0.00123	CcSEcCtD
Ticagrelor—Confusional state—Doxorubicin—sarcoma	0.000297	0.00123	CcSEcCtD
Ticagrelor—Shock—Doxorubicin—sarcoma	0.00029	0.0012	CcSEcCtD
Ticagrelor—Nervous system disorder—Doxorubicin—sarcoma	0.000289	0.00119	CcSEcCtD
Ticagrelor—Skin disorder—Doxorubicin—sarcoma	0.000286	0.00118	CcSEcCtD
Ticagrelor—Paraesthesia—Epirubicin—sarcoma	0.000286	0.00118	CcSEcCtD
Ticagrelor—Dyspnoea—Epirubicin—sarcoma	0.000284	0.00117	CcSEcCtD
Ticagrelor—Dyspepsia—Epirubicin—sarcoma	0.00028	0.00116	CcSEcCtD
Ticagrelor—Hypotension—Doxorubicin—sarcoma	0.000275	0.00114	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Epirubicin—sarcoma	0.000275	0.00113	CcSEcCtD
Ticagrelor—Fatigue—Epirubicin—sarcoma	0.000274	0.00113	CcSEcCtD
Ticagrelor—Constipation—Epirubicin—sarcoma	0.000272	0.00112	CcSEcCtD
Ticagrelor—Paraesthesia—Doxorubicin—sarcoma	0.000264	0.00109	CcSEcCtD
Ticagrelor—Dyspnoea—Doxorubicin—sarcoma	0.000263	0.00108	CcSEcCtD
Ticagrelor—Feeling abnormal—Epirubicin—sarcoma	0.000262	0.00108	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Epirubicin—sarcoma	0.00026	0.00107	CcSEcCtD
Ticagrelor—Dyspepsia—Doxorubicin—sarcoma	0.000259	0.00107	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000254	0.00105	CcSEcCtD
Ticagrelor—Fatigue—Doxorubicin—sarcoma	0.000254	0.00105	CcSEcCtD
Ticagrelor—Constipation—Doxorubicin—sarcoma	0.000252	0.00104	CcSEcCtD
Ticagrelor—Abdominal pain—Epirubicin—sarcoma	0.000252	0.00104	CcSEcCtD
Ticagrelor—Body temperature increased—Epirubicin—sarcoma	0.000252	0.00104	CcSEcCtD
Ticagrelor—Feeling abnormal—Doxorubicin—sarcoma	0.000243	0.001	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Doxorubicin—sarcoma	0.000241	0.000994	CcSEcCtD
Ticagrelor—Hypersensitivity—Epirubicin—sarcoma	0.000234	0.000968	CcSEcCtD
Ticagrelor—Body temperature increased—Doxorubicin—sarcoma	0.000233	0.000961	CcSEcCtD
Ticagrelor—Abdominal pain—Doxorubicin—sarcoma	0.000233	0.000961	CcSEcCtD
Ticagrelor—Asthenia—Epirubicin—sarcoma	0.000228	0.000942	CcSEcCtD
Ticagrelor—Pruritus—Epirubicin—sarcoma	0.000225	0.000929	CcSEcCtD
Ticagrelor—Diarrhoea—Epirubicin—sarcoma	0.000218	0.000899	CcSEcCtD
Ticagrelor—Hypersensitivity—Doxorubicin—sarcoma	0.000217	0.000895	CcSEcCtD
Ticagrelor—Asthenia—Doxorubicin—sarcoma	0.000211	0.000872	CcSEcCtD
Ticagrelor—Dizziness—Epirubicin—sarcoma	0.00021	0.000869	CcSEcCtD
Ticagrelor—Pruritus—Doxorubicin—sarcoma	0.000208	0.00086	CcSEcCtD
Ticagrelor—Vomiting—Epirubicin—sarcoma	0.000202	0.000835	CcSEcCtD
Ticagrelor—Diarrhoea—Doxorubicin—sarcoma	0.000201	0.000832	CcSEcCtD
Ticagrelor—Rash—Epirubicin—sarcoma	0.000201	0.000828	CcSEcCtD
Ticagrelor—Dermatitis—Epirubicin—sarcoma	0.0002	0.000827	CcSEcCtD
Ticagrelor—Headache—Epirubicin—sarcoma	0.000199	0.000823	CcSEcCtD
Ticagrelor—Dizziness—Doxorubicin—sarcoma	0.000195	0.000804	CcSEcCtD
Ticagrelor—Nausea—Epirubicin—sarcoma	0.000189	0.00078	CcSEcCtD
Ticagrelor—Vomiting—Doxorubicin—sarcoma	0.000187	0.000773	CcSEcCtD
Ticagrelor—Rash—Doxorubicin—sarcoma	0.000186	0.000766	CcSEcCtD
Ticagrelor—Dermatitis—Doxorubicin—sarcoma	0.000185	0.000766	CcSEcCtD
Ticagrelor—Headache—Doxorubicin—sarcoma	0.000184	0.000761	CcSEcCtD
Ticagrelor—Nausea—Doxorubicin—sarcoma	0.000175	0.000722	CcSEcCtD
